
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1 | -5.71755288736 | 17.49 | 17.575 | 10.01 | 36010 | 16.67505828 | CS |
4 | -2.32 | -12.3338649654 | 18.81 | 19.04 | 10.01 | 36778 | 17.42773995 | CS |
12 | -4.73 | -22.2902921772 | 21.22 | 22.18 | 10.01 | 57932 | 18.53033569 | CS |
26 | -1.51 | -8.38888888889 | 18 | 25.4985 | 10.01 | 85121 | 20.00594897 | CS |
52 | -11.31 | -40.6834532374 | 27.8 | 28.172 | 10.01 | 75973 | 20.23827318 | CS |
156 | -1.08 | -6.1468412066 | 17.57 | 33 | 1.77 | 207513 | 13.18344434 | CS |
260 | -8.51 | -34.04 | 25 | 42.86 | 1.77 | 164325 | 14.03327997 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales